Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer

A phase II study of cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony stimulating factor (rhG-CSF) support was conducted in previously untreated patients with stage IIIB or IV non-small-cell lung cancer (NSCLC). Between June 1998 and August 2001, 50 patients were regist...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, A, Ohkubo, T, Hoshino, H, Takabatake, H, Tagaki, S, Sekine, K, Abe, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376953/
https://www.ncbi.nlm.nih.gov/pubmed/12966417
http://dx.doi.org/10.1038/sj.bjc.6601230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376953/
https://www.ncbi.nlm.nih.gov/pubmed/12966417
http://dx.doi.org/10.1038/sj.bjc.6601230

Ejemplares similares